Clinical Trial

A Multicenter, Post-Market Clinical Follow-up Study of Subjects With the REDAPT™ System Monolithic Sleeveless/Sleeved Stem and/or Fully Porous Acetabular Shell With XLPE Liner and/or Modular Shell Components Previously Implanted

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The primary purpose of this study is to demonstrate cumulative revision rate of the REDAPT System Monolithic Sleeveless/Sleeved Stem, Fully Porous Acetabular Shell with XLPE liner, and Modular Shell Components (with or without Staple, Slice and Blade Augments) at 10 years.
Protocol Amendment History 14 amendments
This ClinicalTrials.gov record has been amended 14 times since 2018-07-26; most recent amendment 2025-01-02.
Status change: Recruiting → Enrolling by Invitation 2018-10-19
Trial Details
NCT Number NCT03610789
Lead Sponsor Smith & Nephew, Inc.
Conditions Hip Replacement
Enrollment 220 participants
Start Date 2018-05-07
Primary Completion 2034-07-01 (estimated)
Study Completion 2034-07-01 (estimated)
Updated on ClinicalTrials.gov 2025-01-06